Boston Scientific Corp. insider trading
In the last twelve months insiders at Boston Scientific Corp. filed 11 open-market sales worth $29.3 million and 10 open-market purchases worth $10.0 million, on Form 4 with the SEC. The latest: Morano Susan E, Director, bought 2,040 shares at $49.22 on 25 August 2026, filed 26 August 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 25 August 2026 | Morano Susan E | Director | Purchase | 2,040 | $49.22 | $100,408 | Form 4 |
| 5 August 2026 | Habiger David C | Director | Purchase | 2,100 | $47.59 | $99,937 | Form 4 |
| 4 August 2026 | Habiger David C | Director | Purchase | 140 | $48.59 | $6,802 | Form 4 |
| 3 August 2026 | Habiger David C | Director | Purchase | 1,042 | $48.07 | $50,084 | Form 4 |
| 3 August 2026 | Mahoney Michael F | Chairman, President & CEO | Purchase | 186,240 | $48.33 | $9.0 million | Form 4 |
| 31 July 2026 | Ludwig Edward J | Director | Purchase | 5,000 | $45.48 | $227,400 | Form 4 |
| 20 May 2026 | Pegus Cheryl | Director | Purchase | 1,770 | $56.49 | $99,987 | Form 4 |
| 20 May 2026 | Ludwig Edward J | Director | Purchase | 3,580 | $56.68 | $202,914 | Form 4 |
| 20 May 2026 | Habiger David C | Director | Purchase | 2,250 | $55.92 | $125,819 | Form 4 |
| 19 May 2026 | Habiger David C | Director | Purchase | 2,200 | $56.95 | $125,279 | Form 4 |
| 2 February 2026 | Mahoney Michael F | Chairman, President & CEO | Sale | 1,200 | $94.06 | $112,868 | Form 4 |
| 2 February 2026 | Mahoney Michael F | Chairman, President & CEO | Sale | 159,701 | $93.49 | $14.9 million | Form 4 |
| 1 December 2025 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sale | 17,313 | $101.55 | $1.8 million | Form 4 |
| 6 November 2025 | Zane Ellen M | Director | Sale | 12,891 | $98.28 | $1.3 million | Form 4 |
| 3 November 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sale | 3,600 | $100.75 | $362,693 | Form 4 |
| 3 November 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sale | 16,928 | $99.76 | $1.7 million | Form 4 |
| 3 November 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sale | 29,472 | $99.14 | $2.9 million | Form 4 |
| 28 October 2025 | Zane Ellen M | Director | Sale | 2,901 | $102.24 | $296,599 | Form 4 |
| 27 October 2025 | Zane Ellen M | Director | Sale | 9,990 | $101.13 | $1.0 million | Form 4 |
| 1 October 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sale | 8,245 | $98.91 | $815,482 | Form 4 |
| 1 October 2025 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sale | 41,755 | $98.38 | $4.1 million | Form 4 |
Open-market purchases (code P) and sales (code S) only. Option exercises, grants, tax withholding and gifts are not shown. A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Boston Scientific Corp.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.